Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2
Indian Journal of Ophthalmology · 2023
DOI: 10.4103/ijo.ijo_2640_22 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Josef Finsterer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neurology and Neurophysiology Center, Vienna, Austria. Hauptthemen laut MEDLINE: Blindness, Cortical, COVID-19. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Dear Editor, We read with interest the article by Mahajan and Phuljhele[1] about a 61-year-old male with cortical blindness due to bilateral ischemic stroke, 1 week after he received the first dose of an anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) vaccine (Covishield).[1] The study raises concerns. In addition to arterial hypertension, hyperlipidemia, diabetes, and smoking, which were ruled out as causes of ischemic stroke in the index patient by Mahajan and Phuljhele[1] already, it would be interesting to know whether occlusion, stenosis, spasm, or dissection of posterior cerebral arteries, basilar artery, or vertebral arteries were ruled out as causes of the index patient’s stroke by computed tomography or magnetic resonance angiography. Since the prevalence of atrial fibrillation increases with age,[2] the exclusion of atrial fibrillation by long-term electrocardiogram (ECG) recordings is imperative. In addition, left atrial, left atrial appendage, left ventricular thrombus formation, acute heart failure, and endocarditis, myocarditis, or Takotsubo syndrome should be excluded by echocardiography. It should be reported whether the patient has ever complained about palpitations, leg edema, or exertional dyspnea. It should also be mentioned whether creatine kinase (CK), CK-MB, troponin, or pro-brain natriuretic peptide was elevated. Since the patient reported headache before the onset of visual disturbance, it is mandatory that venous sinus thrombosis (VST) is ruled out as the cause of stroke by measurement of D-dimer and by venous computed tomography (CT) or magnetic resonance imaging (MRI) angiography. It should be mentioned whether ischemic stroke was in the acute or subacute stage on multimodal MRI and what acute and long-term treatment of ischemic stroke was applied, particularly whether the patient received systemic or local thrombolysis or thrombectomy. It should also be mentioned what long-term antithrombotic treatment was used, particularly whether the patient was receiving antithrombotic treatment or anticoagulation with vitamin-K antagonists or a direct oral anticoagulant (DOAC). Before blaming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination for acute occipital stroke, various differential pathophysiological explanations need to be ruled out. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Neurology and Neurophysiology Center, Vienna, Austria.
- Biochemistry Laboratory, LR12ES05 "Nutrition-Functional Foods and Vascular Health", Faculty of Medicine, Monastir, Tunisia.
Zitieren
APA
Finsterer, J., & Mehri, S. (2023). Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2640_22
Vancouver
Finsterer J, Mehri S. Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_2640_22
BibTeX
@article{Finsterer2023,
author = {Finsterer, Josef and Mehri, Sounira},
title = {Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2},
journal = {Indian Journal of Ophthalmology},
year = {2023},
doi = {10.4103/ijo.ijo_2640_22}
}
EUVIMED